UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic HER2 Negative Breast Carcinoma · Brain Metastases · Capecitabine · UDT1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Quchang Ouyang, Changsha, China
Contact: Study coordinator (Quchang Ouyang) · oyqc1969@126.com · +8673189762161

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Breast Neoplasms

IsraelRecruitingPHASE3

Daphne, United States · Tucson, United States

Mobile Health for Adherence in Breast Cancer Patients

Anatomic Stage IV Breast Cancer AJCC v8 · Breast Carcinoma · HER2-Negative Breast Carcinoma

Abroad (travel likely)Recruiting

Fairbanks, United States · Kingman, United States

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Metastatic Breast Cancer · Stage IV Breast Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer · Advanced Breast Cancer · Metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Tucson, United States · Fountain Valley, United States